Certain immune cells in MS show abnormalities in activity and signs of reactions against the Epstein-Barr virus, a study says ...

EBV antibodies trigger MS by attacking brain proteins. Genetic factors worsen risk. Breakthrough insights for treatment.

Study finds antibodies that target Epstein-Barr virus proteins can also attack proteins in the brain, increasing the likelihood of MS.

Scientists from Sweden’s Karolinska Institutet have uncovered new clues about how the Epstein-Barr virus (EBV) might contribute to multiple sclerosis (MS), a disease that affects the brain and spinal ...

[46] Evidence supporting a role for EBV infection in MS pathogenesis come from ecological studies, observational epidemiological studies, co-occurring pathologies and experimental laboratory-based ...

The Epstein-Barr virus (EBV) is one of the most common human viruses worldwide. According to the Centers for Disease Control and Prevention (CDC), EBV can | Immunology ...

The risk of developing MS and other demyelinating diseases is 3 times greater in individuals diagnosed with EBV-positive IM.

In multiple sclerosis (MS), antibodies to the common Epstein-Barr virus can accidentally attack a protein in the brain and spinal cord. New research shows that the combination of certain viral ...

The etiologies of multiple sclerosis (MS) and systemic lupus erythematosus (SLE) are still unknown, but a growing body of evidence indicates that EBV could act as a trigger of both diseases.

Genes combined with immune response to Epstein-Barr virus increase MS risk. ScienceDaily . Retrieved March 24, 2025 from www.sciencedaily.com / releases / 2025 / 03 / 250310152912.htm ...